ArticleEuropean journal of epidemiology2026
Association between overall dietary antioxidant capacity and lung cancer risk: findings from two observational studies.
Article in European journal of epidemiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
While individual antioxidants such vitamins A, C, and E have shown potential advantages in cancer prevention, the comprehensive impact of combined dietary antioxidant consumption on the development and progression of lung cancer requires additional clarification. In this research, we looked at the relationship between the risk of lung cancer in independent populations and the use of composite antioxidants. A case-control study including lung cancer patients and control participants from the Healthy Zhejiang One Million People (HOPE) study (enrolled between 2022 and 2024), as well as a prospective cohort study involving participants from the UK Biobank, were conducted. From the UK Biobank, baseline data was gathered between 2009 and 2010, and follow-up was prolonged until December 19, 2022. Intakes of six minerals and vitamins assessed using a food frequency questionnaire were used to develop a composite dietary antioxidant index (CDAI) and a dietary antioxidant quality score (DAQS). The relationships were quantified using Logistic regression for the case-control study and Cox proportional hazards models for the cohort study. Additional sensitivity and subgroup analysis were conducted. After multivariable adjustment, high dietary antioxidant intake (highest vs. lowest tertile) was consistently associated with a marked reduction in lung cancer risk across both the HOPE study (CDAI: OR = 0.43, 95% CI: 0.28-0.65, p < 0.001; DAQS: OR = 0.54, 95% CI: 0.36-0.82, p = 0.003) and the UK Biobank (CDAI: HR = 0.59, 95% CI: 0.41-0.84, p = 0.004; DAQS: HR = 0.56, 95% CI: 0.39-0.82, p = 0.003). These associations were consistent across all subgroup and sensitivity analyses. These findings reinforce the role of elevated dietary antioxidant consumption as a protective factor against lung cancer, offering valuable insights for dietary prevention strategies in at-risk individuals.
Indexed as
Identifiers
42862260What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.